Clinical trial
Efficacy and Safety of Artemether Lumefantrine for the Treatment of Uncomplicated Malaria in Tanzania
NCT03387631 is registered in ClinicalTrials.gov with National Institute for Medical Research, Tanzania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Artemether Lumefantrine for the Treatment of Uncomplicated Malaria in Tanzania
- Lead sponsor
- National Institute for Medical Research, Tanzania
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- September 30, 2016
- Enrollment
- 344 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
uncomplicated malaria